Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2022-06-27 00:00:00 ET · period of report 2022-06-23 · accession 0001140361-22-024161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-27 | 2022-06-23 | ATRA | Baynes Roy D. | Dir | A - Grant | $0.00 | +20.5K | 43.5K | +89% | $0 |
| D | 2022-06-27 | 2022-06-23 | ATRA | Baynes Roy D. | Dir | A - Grant | $0.00 | +31.5K | 31.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-23 | A | A | 20,500 | $0.00 | 43,500 | D | — | — | (F1) These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service. |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-06-23 | A | A | 31,500 | $0.00 | 31,500 | D | $7.35 · — to 2032-06-22 | 31,500 Common Stock | (F2) The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service. |